Want to contact a Zetia lawyer in District of Columbia? ...Get a free case evaluation from one of our Zetia lawyers in District of Columbia now.
Home : Unsafe Drugs : Zetia : MSN Newsfeeds
Zetia - MSN Newsfeeds
- InteliHealth - Two very popular drugs, Zetia and Vytorin, were shown to be less effective than presumed. There was a one-month delay in getting the information out. In the past, however, it may never have been made public. We need to keep even so-called negative ...
- Forbes - In a statement, Schering-Plough CEO Fred Hassan said the investment reflects his long-term confidence in the company, its cholesterol drugs Zetia and Vytorin, and its late-stage drug pipeline. He also criticized the media's coverage of the trial ...
- Forbes - Hassan said his purchase reflects his long-term confidence in the company and its products, including cholesterol medication Zetia and Vytorin, and called the recent media interpretations of results from a trial involving Vytorin and the subsequent ...
- Reuters - In a statement, Schering-Plough CEO Fred Hassan said the investment reflects his long-term confidence in the company, the cholesterol drugs Zetia and Vytorin, and its late-stage drug pipeline. He also criticized the media's coverage of the trial ...
- Phramalive.com - ... November 2003 when I purchased $4.68 million in Schering-Plough Common Shares at an average price of $15.42 (2003 press release below), this investment in Schering-Plough reflects my long-term confidence in the company, its products (including ZETIA ...
- Bloomberg - Merck & Co. and Schering-Plough Corp. of the U.S. were accused in a lawsuit of breaking consumer-protection laws by promoting cholesterol-lowering drugs Zetia and Vytorin when they knew they weren't any more effective than generics. AstraZeneca ...
- Medical News Today - For the study, led by John Kastelein of the University of Amsterdam Medical Center , 720 participants took either Vytorin -- a combination of Zetia, which blocks absorption of cholesterol in the intestines, and Zocor, a statin available in generic ...
- Health and Age.com - How could a drug that seems to make a condition worse actually get approved for sale by the FDA? The answer lies in the term "surrogate markers", which I'll discuss below. Zetia® (ezetimibe) is a cholesterol-lowering drug that works in a different ...
- Pravda - The results of a clinical trial released Monday found that Vytorin did not reduce the buildup of harmful plaque in arteries any better than a much cheaper generic drug. Ezetimibe/simvastatin is a drug combination used for the treatment of ...
- Forbes - Vytorin is a single pill combination of two drugs Zocor and Zetia and was approved for use by the FDA in 2004. The companies shares fell at the close of trade yesterday. Merck stock dropped 3.48 usd, or 6 pct, to 54.87 usd, while Schering-Plough fell ...
- Forbes - The statin-ezetimibe combination reduced LDL-C more than did the statin alone. However, there were no statistically significant differences in the primary endpoint, which was carotid intimal- media thickness, as measured by ultrasound. The ...
- Independent Online - Vytorin combines two cholesterol-lowering drugs - ezetimibe, sold under the brand name Zetia, and simvastatin, sold generically and under the Zocor brand name. The study involved 720 patients with very high levels of cholesterol from an inherited form ...
- eMaxHealth.com - Zetia (ezetimibe) "may not actually prevent heart attacks and strokes," according to the long-awaited results of the Enhance trial. Typically, patients "take Zetia in the form of Vytorin (ezetimibe and simvastatin), which combines Zetia with Zocor ...
- Forbes - Vytorin(R) is a single pill combination of two drugs, Zocor and Zetia, (ezetimibe plus simvastatin). The lawsuit alleges that Merck & Co., Inc. and Schering-Plough Corporation, the manufacturers of the prescription drug, Vytorin(R), made ...
- Reuters UK - Vytorin combines two cholesterol-lowering drugs -- ezetimibe, sold under the brand name Zetia, and simvastatin, sold generically and under the Zocor brand name. Continued... © Reuters 2008. All Rights Reserved. | Learn more about Reuters
- Health 24 - ... cholesterol-lowering drug prescribed to about a million Americans, shows the drug confers no medical benefit to users. In fact, the pace at which artery-clogging plaques formed within vessels almost doubled in patients taking Zetia (ezetimibe) along ...
- HealthCentral.com - Vytorin combines two cholesterol-lowering drugs -- ezetimibe, sold under the brand name Zetia, and simvastatin, sold generically and under the Zocor brand name. 720 PATIENTS The study involved 720 patients with very high levels of cholesterol from an ...
- Forbes - SEATTLE, Jan. 16 /PRNewswire/ -- Hagens Berman Sobol Shapiro has begun an investigation concerning actions by Merck (NYSE: MRK) and Schering-Plough (NYSE: SGP), manufacturers of Zetia and Vytorin. The investigation is looking into charges of whether ...
- Baltimore Sun - While known for allergy and hepatitis-C products, Schering-Plough is enjoying a powerful income stream from the popular cholesterol drugs Zetia and Vytorin, developed in a joint venture with Merck & Co. Its stock is up 25 percent this year, after ...
- Tacoma News Tribune - Singulair is my top seller, and my other offerings include Cozaar, Hyzaar, Fosamax, Januvia, Vytorin and Zetia. In 2003, I spun off Medco, a pharmacy-benefit manager, and in 2006 I withdrew Vioxx. I’ve donated medicine to the needy for decades and ...
Want to contact a Zetia lawyer in District of Columbia? ...Get a free case evaluation from one of our Zetia lawyers in District of Columbia now.
Pages: 1 2 3 4 5 6 ... Next
